Previous Article | Next Article 
Infection and Immunity, December 2001, p. 7927-7932, Vol. 69, No. 12
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7927-7932.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Characterization of Chlamydia
pneumoniae Persistence in HEp-2 Cells Treated with
Gamma Interferon
Laura G.
Pantoja,1,2
Richard D.
Miller,2
Julio A.
Ramirez,1
Robert E.
Molestina,1 and
James T.
Summersgill1,2,*
Division of Infectious Diseases, Department
of Medicine,1 and Department of
Microbiology and Immunology,2 University of
Louisville School of Medicine, Louisville, Kentucky 40292
Received 27 March 2001/Returned for modification 8 June
2001/Accepted 23 August 2001
Infection with Chlamydia pneumoniae has been
implicated as a potential risk factor for atherosclerosis. This study
demonstrated the effects of gamma interferon (IFN-
)-mediated
indoleamine 2,3-dioxygenase activity on C. pneumoniae
persistence in HEp-2 cells, inclusion morphology, and ultrastructure.
C. pneumoniae replication showed a dose-dependent
decrease when treated with increasing concentrations of IFN-
and a
phenotypic switch resulting in a decrease in typical inclusions with an
increase in smaller, less-dense atypical inclusions. Ultrastructural
analysis of IFN-
-treated C. pneumoniae revealed atypical inclusions containing large reticulatate-like aberrant bodies with no evidence of redifferentiation into elementary bodies.
*
Corresponding author. Mailing address: Infectious
Diseases Laboratory, Room 311, Instructional Building, 500 South
Preston St., University of Louisville, Louisville, KY 40292. Phone:
(502) 852-5132. Fax: (502) 852-1512. E-mail:
jtsumm{at}louisville.edu.
Infection and Immunity, December 2001, p. 7927-7932, Vol. 69, No. 12
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7927-7932.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Vanover, J., Sun, J., Deka, S., Kintner, J., Duffourc, M. M., Schoborg, R. V.
(2008). Herpes simplex virus co-infection-induced Chlamydia trachomatis persistence is not mediated by any known persistence inducer or anti-chlamydial pathway. Microbiology
154: 971-978
[Abstract]
[Full Text]
-
Palikhe, A., Lokki, M.-L., Saikku, P., Leinonen, M., Paldanius, M., Seppanen, M., Valtonen, V., Nieminen, M. S., Sinisalo, J.
(2008). Association of Chlamydia pneumoniae Infection with HLA-B*35 in Patients with Coronary Artery Disease. CVI
15: 55-59
[Abstract]
[Full Text]
-
Eickhoff, M., Thalmann, J., Hess, S., Martin, M., Laue, T., Kruppa, J., Brandes, G., Klos, A.
(2007). Host Cell Responses to Chlamydia pneumoniae in Gamma Interferon-Induced Persistence Overlap Those of Productive Infection and Are Linked to Genes Involved in Apoptosis, Cell Cycle, and Metabolism. Infect. Immun.
75: 2853-2863
[Abstract]
[Full Text]
-
Droemann, D., Rupp, J., Goldmann, T., Uhlig, U., Branscheid, D., Vollmer, E., Kujath, P., Zabel, P., Dalhoff, K.
(2007). Disparate Innate Immune Responses to Persistent and Acute Chlamydia pneumoniae Infection in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med.
175: 791-797
[Abstract]
[Full Text]
-
Goellner, S., Schubert, E., Liebler-Tenorio, E., Hotzel, H., Saluz, H. P., Sachse, K.
(2006). Transcriptional Response Patterns of Chlamydophila psittaci in Different In Vitro Models of Persistent Infection.. Infect. Immun.
74: 4801-4808
[Abstract]
[Full Text]
-
Mukhopadhyay, S., Miller, R. D., Sullivan, E. D., Theodoropoulos, C., Mathews, S. A., Timms, P., Summersgill, J. T.
(2006). Protein Expression Profiles of Chlamydia pneumoniae in Models of Persistence versus Those of Heat Shock Stress Response. Infect. Immun.
74: 3853-3863
[Abstract]
[Full Text]
-
Rahman, Mohd. A., Azuma, Y., Fukunaga, H., Murakami, T., Sugi, K., Fukushi, H., Miura, K., Suzuki, H., Shirai, M.
(2005). Serotonin and melatonin, neurohormones for homeostasis, as novel inhibitors of infections by the intracellular parasite chlamydia. J Antimicrob Chemother
56: 861-868
[Abstract]
[Full Text]
-
Hogan, R. J., Mathews, S. A., Mukhopadhyay, S., Summersgill, J. T., Timms, P.
(2004). Chlamydial Persistence: beyond the Biphasic Paradigm. Infect. Immun.
72: 1843-1855
[Full Text]
-
Su, H., McClarty, G., Dong, F., Hatch, G. M., Pan, Z. K., Zhong, G.
(2004). Activation of Raf/MEK/ERK/cPLA2 Signaling Pathway Is Essential for Chlamydial Acquisition of Host Glycerophospholipids. J. Biol. Chem.
279: 9409-9416
[Abstract]
[Full Text]
-
Yoneda, H., Miura, K., Matsushima, H., Sugi, K., Murakami, T., Ouchi, K., Yamashita, K., Itoh, H., Nakazawa, T., Suzuki, M., Shirai, M.
(2003). Aspirin inhibits Chlamydia pneumoniae-induced NF-{kappa}B activation, cyclo-oxygenase-2 expression and prostaglandin E2 synthesis and attenuates chlamydial growth. J Med Microbiol
52: 409-415
[Abstract]
[Full Text]
-
Sakash, J. B., Byrne, G. I., Lichtman, A., Libby, P.
(2002). Cytokines Induce Indoleamine 2,3-Dioxygenase Expression in Human Atheroma-Associated Cells: Implications for Persistent Chlamydophila pneumoniae Infection. Infect. Immun.
70: 3959-3961
[Abstract]
[Full Text]
-
Molestina, R. E., Klein, J. B., Miller, R. D., Pierce, W. H., Ramirez, J. A., Summersgill, J. T.
(2002). Proteomic Analysis of Differentially Expressed Chlamydia pneumoniae Genes during Persistent Infection of HEp-2 Cells. Infect. Immun.
70: 2976-2981
[Abstract]
[Full Text]